Employees: 21 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: ETICreation date: 2006-05-02 (20 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: PUTEAUX (92800), Hauts-de-Seine
SWEDISH ORPHAN BIOVITRUM : revenue, balance sheet and financial ratios
SWEDISH ORPHAN BIOVITRUM is a French company
founded 20 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in PUTEAUX (92800),
this company of category ETI
shows in 2023 a revenue of 144.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SWEDISH ORPHAN BIOVITRUM (SIREN 490259405)
Indicator
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
143 979 269 €
159 902 380 €
185 017 377 €
194 527 087 €
198 313 200 €
153 301 780 €
78 701 684 €
24 033 282 €
Net income
6 034 154 €
3 832 098 €
4 933 238 €
3 752 691 €
2 600 648 €
1 847 794 €
2 188 000 €
379 785 €
EBITDA
9 031 783 €
6 640 411 €
8 519 725 €
7 320 764 €
6 232 031 €
4 543 772 €
4 430 987 €
828 138 €
Net margin
4.2%
2.4%
2.7%
1.9%
1.3%
1.2%
2.8%
1.6%
Revenue and income statement
In 2023, SWEDISH ORPHAN BIOVITRUM achieves revenue of 144.0 M€. Over the period 2016-2023, the company shows strong growth with a CAGR (compound annual growth rate) of +29.1%. Slight decline of -10% vs 2022. After deducting consumption (108.8 M€), gross margin stands at 35.2 M€, i.e. a rate of 24%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 9.0 M€, representing 6.3% of revenue. Positive scissor effect: EBITDA margin improves by +2.1 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 6.0 M€, i.e. 4.2% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2023)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
143 979 269 €
Gross margin (2023)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
35 166 595 €
EBITDA (2023)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
9 031 783 €
EBIT (2023)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
8 929 704 €
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
6 034 154 €
EBITDA margin (2023)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
6.3%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 53%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 38%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.2 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 4.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
52.624%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
37.984%
Cash flow / Revenue (2023)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
4.273%
Repayment capacity (2023)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
2.217
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SWEDISH ORPHAN BIOVITRUM
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Debt ratio
49.508
384.017
597.064
466.651
339.051
164.181
115.824
52.624
Financial autonomy
6.837
9.527
9.619
10.677
14.434
22.303
26.5
37.984
Repayment capacity
1.256
4.848
15.099
11.893
9.668
5.038
5.85
2.217
Cash flow / Revenue
1.211%
2.945%
1.231%
1.459%
2.006%
2.828%
2.462%
4.273%
Sector positioning
Debt ratio
52.622023
2021
2022
2023
Q1: 0.0
Med: 5.57
Q3: 50.77
Average
In 2023, the debt ratio of SWEDISH ORPHAN BIOVITRUM (52.62) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
37.98%2023
2021
2022
2023
Q1: 13.47%
Med: 38.42%
Q3: 58.45%
Average+18 pts over 3 years
In 2023, the financial autonomy of SWEDISH ORPHAN BIOVITRUM (38.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
2.22 years2023
2021
2022
2023
Q1: 0.0 years
Med: 0.0 years
Q3: 1.46 years
Average
In 2023, the repayment capacity of SWEDISH ORPHAN BIOVITRUM (2.22) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 237.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.5x. Coverage is limited: any activity downturn would jeopardize interest payments.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
237.882
Interest coverage (2023)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
1.515
Liquidity indicators evolution SWEDISH ORPHAN BIOVITRUM
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
107.752
184.55
300.237
250.875
270.193
244.207
233.405
237.882
Interest coverage
12.609
2.658
3.73
2.261
2.269
2.798
3.45
1.515
Sector positioning
Liquidity ratio
237.882023
2021
2022
2023
Q1: 133.58
Med: 205.53
Q3: 329.15
Good
In 2023, the liquidity ratio of SWEDISH ORPHAN BIOVITRUM (237.88) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
1.51x2023
2021
2022
2023
Q1: 0.0x
Med: 0.29x
Q3: 6.06x
Good-9 pts over 3 years
In 2023, the interest coverage of SWEDISH ORPHAN BIOVITRUM (1.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 62 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 6 days. The gap of 56 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 93 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 104 days of revenue, i.e. 41.5 M€ to permanently finance. Over 2016-2023, WCR increased by +2509%, requiring additional financing.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
41 549 537 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
62 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
6 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
93 j
WCR in days of revenue (2023)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
104 j
WCR and payment terms evolution SWEDISH ORPHAN BIOVITRUM
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Operating WCR
1 592 445 €
15 948 109 €
34 471 438 €
43 866 880 €
49 983 735 €
44 013 784 €
44 070 695 €
41 549 537 €
Inventory turnover (days)
52
50
35
38
87
55
97
93
Customer payment term (days)
81
65
61
53
44
43
56
62
Supplier payment term (days)
16
10
7
5
4
4
3
6
Positioning of SWEDISH ORPHAN BIOVITRUM in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Based on 124 transactions of similar company sales
(all years),
the value of SWEDISH ORPHAN BIOVITRUM is estimated at
13 369 268 €
(range 6 868 507€ - 43 054 209€).
With an EBITDA of 9 031 783€, the sector multiple of 0.7x is applied.
The price/revenue ratio is 0.21x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
124 transactions
6868k€13369k€43054k€
13 369 268 €Range: 6 868 507€ - 43 054 209€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
9 031 783 €×0.7x
Estimation6 357 338 €
3 005 340€ - 23 138 390€
Revenue Multiple30%
143 979 269 €×0.21x
Estimation30 663 898 €
16 628 305€ - 92 881 453€
Net Income Multiple20%
6 034 154 €×0.8x
Estimation4 957 152 €
1 886 728€ - 18 102 890€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare SWEDISH ORPHAN BIOVITRUM with other companies in the same sector:
Frequently asked questions about SWEDISH ORPHAN BIOVITRUM
What is the revenue of SWEDISH ORPHAN BIOVITRUM ?
The revenue of SWEDISH ORPHAN BIOVITRUM in 2023 is 144.0 M€.
Is SWEDISH ORPHAN BIOVITRUM profitable?
Yes, SWEDISH ORPHAN BIOVITRUM generated a net profit of 6.0 M€ in 2023.
Where is the headquarters of SWEDISH ORPHAN BIOVITRUM ?
The headquarters of SWEDISH ORPHAN BIOVITRUM is located in PUTEAUX (92800), in the department Hauts-de-Seine.
Where to find the tax return of SWEDISH ORPHAN BIOVITRUM ?
The tax return of SWEDISH ORPHAN BIOVITRUM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SWEDISH ORPHAN BIOVITRUM operate?
SWEDISH ORPHAN BIOVITRUM operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart